TBT
BMY icon

Texas Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Texas Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Sell
8,135
-300
-4% -$17.2K 0.15% 128
2026
Q1 		$512K Sell
8,435
-640
-7% -$37.3K 0.19% 112
2025
Q4 		$490K Hold
9,075
– – 0.18% 117
2025
Q3 		$409K Sell
9,075
-305
-3% -$14.2K 0.15% 123
2025
Q2 		$434K Sell
9,380
-122
-1% -$5.99K 0.17% 123
2025
Q1 		$580K Sell
9,502
-3,713
-28% -$216K 0.25% 99
2024
Q4 		$747K Buy
+13,215
New +$738K 0.31% 90

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Texas Bank & Trust's BMY Position: Q2 2026 in Review

Texas Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 3.6% in Q2 2026, selling an estimated $17.2K and leaving 8,135 shares worth $469K. The position accounts for 0.15% of the portfolio, ranked #128.

Texas Bank & Trust first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $747K in Q4 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Texas Bank & Trust held 8,135 shares of Bristol-Myers Squibb worth $469K as of Q2 2026.
  • Texas Bank & Trust sold 300 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.2K.
  • Bristol-Myers Squibb made up 0.15% of Texas Bank & Trust's portfolio in Q2 2026, its #128 holding.
  • Texas Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Texas Bank & Trust's Bristol-Myers Squibb position peaked at $747K in Q4 2024.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.